Blueprint Medicines Corporation logo
Blueprint Medicines Corporation BPMC
report update icon

Quartalsbericht 2025-Q1
hinzugefügt 16.05.2026

Blueprint Medicines Corporation ROE | BPMC

ROE Jährlich Blueprint Medicines Corporation

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-22.46 -388.17 -108.32 -66.35 21.35 -74.88 -56.48 -23.74 -34.02 -36.65 - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
21.35 -388.17 -78.97

ROE Vierteljährlich Blueprint Medicines Corporation

2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-4.75 -4.89 -70.89 -95.6 -111.26 -139.95 -160.74 -116.11 -85.45 -54.18 -63.58 -50.94 -36.71 -24.68 18.44 19.44 20.06 27.18 12.89 -50.53 -63.6 -74.88 -79.76 -76.81 -61.8 -56.48 -45.16 -33.85 -32.75 -23.74 -25.86 -27.72 -31.23 -34.02 -34.86 -35.74 -35.89 -36.65 -7.61 14.4 33.86 50.75 13.23 10.44 8.85 - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
50.75 -160.74 -36.87

ROE anderer Aktien in der Pharmaeinzelhändler

Name ROE Preis % 24h Marktkapitalisierung Land
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
43.5 - -0.04 % $ 2.62 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
-782.6 - -74.18 % $ 955 K usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
-197.53 - -23.04 % $ 26.6 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
-33.6 - - $ 3.67 B usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
-84.78 - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
-123.92 - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
1.94 - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
6.42 - - $ 109 M usaUSA
Akouos Akouos
AKUS
-37.09 - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
-143.06 - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
-74.53 - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
-103.99 - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
607.06 - - $ 591 K irlandaIrlanda
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
1320.61 - -45.12 % $ 2.85 M usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
179.91 - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
115.97 - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
-558.64 - 31.87 % $ 1.61 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
45.18 - -4.8 % $ 255 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
-19.38 - -0.23 % $ 916 M usaUSA
bluebird bio bluebird bio
BLUE
763.35 - - $ 546 M usaUSA
Landos Biopharma Landos Biopharma
LABP
-69.0 - 0.58 % $ 144 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
-92.01 - - $ 35.4 M usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
549.72 - -5.16 % $ 5.39 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
-111.29 - - $ 728 M usaUSA
Regulus Therapeutics Regulus Therapeutics
RGLS
-60.67 - - $ 155 M usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
-95.79 - - $ 127 M usaUSA
Aravive Aravive
ARAV
-716.17 - -13.39 % $ 1.45 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
-88.4 - - $ 231 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
-46.9 $ 84.95 0.13 % $ 7.99 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
156.54 - 2.71 % $ 14 M usaUSA
Gilead Sciences Gilead Sciences
GILD
37.48 $ 166.01 -0.31 % $ 207 B usaUSA
Assembly Biosciences Assembly Biosciences
ASMB
-2.96 $ 22.14 -1.6 % $ 248 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
4.58 - - $ 2.02 B usaUSA
Turning Point Therapeutics Turning Point Therapeutics
TPTX
-24.78 - -0.13 % $ 3.73 B usaUSA
Orgenesis Orgenesis
ORGS
128.44 - -33.86 % $ 61.2 M usaUSA
TCR2 Therapeutics TCR2 Therapeutics
TCRR
-107.78 - - $ 58.1 M usaUSA
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited
ASLN
332.81 - -14.27 % $ 1.7 M singaporeSingapore
Adverum Biotechnologies Adverum Biotechnologies
ADVM
-185.15 - - $ 86.2 M usaUSA
BELLUS Health BELLUS Health
BLU
-19.46 - - $ 2.47 B canadaCanada
Intra-Cellular Therapies Intra-Cellular Therapies
ITCI
-1.47 - - $ 13.6 B usaUSA
Marinus Pharmaceuticals Marinus Pharmaceuticals
MRNS
-843.45 - - $ 29.6 M usaUSA
GeoVax Labs GeoVax Labs
GOVX
-251.41 $ 1.83 -4.45 % $ 8.35 M usaUSA
Unity Biotechnology Unity Biotechnology
UBX
-400.22 - -33.41 % $ 3.37 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
-207.64 - - $ 10.1 M usaUSA
Tyme Technologies Tyme Technologies
TYME
-29.5 - 8.07 % $ 54 M usaUSA
Karuna Therapeutics Karuna Therapeutics
KRTX
-34.58 - - $ 12.2 B usaUSA
Corner Growth Acquisition Corp. Corner Growth Acquisition Corp.
COOL
108.33 - -0.89 % $ 114 M usaUSA
Revance Therapeutics Revance Therapeutics
RVNC
213.71 - - $ 309 M usaUSA
Aptinyx Aptinyx
APTX
-169.38 - -39.0 % $ 4.57 M usaUSA
TRACON Pharmaceuticals TRACON Pharmaceuticals
TCON
443.51 - -1.38 % $ 46.8 M usaUSA